QR Kodea

Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque

Among the vaccines have been developed thus far against SARS-CoV-2, the mRNA-based ones have demonstrated more promising results regarding both safety and efficacy. Two remarkable features of the mRNA vaccines introduced by the Pfizer/BioNTech and Moderna companies are the use of (N<sup>1</sup>-meth...

Deskribapen osoa

Gorde:
Egile Nagusiak: Alireza Naderi Sohi, Jafar Kiani, Ehsan Arefian, Arezou Khosrojerdi, Zahra Fekrirad, Shokoofeh Ghaemi, Mohammad Kazem Zim, Arsalan Jalili, Nazila Bostanshirin, Masoud Soleimani
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2021-09-01
Saila:Vaccines
Gaiak:
mRNA-vaccine
lipid nanoparticle
LNP
SARS-CoV-2
spike protein
Sarrera elektronikoa:https://www.mdpi.com/2076-393X/9/9/1007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak